Patent details

EP3178849 Title: COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS

Basic Information

Publication number:
EP3178849
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP161974597
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS
French Title of Invention:
COMBINAISON D'ANTICORPS ANTI-LAG-3 ET D'ANTICORPS ANTI-PD-1 POUR TRAITER DES TUMEURS
German Title of Invention:
KOMBINATION AUS ANTI-LAG-3-ANTIKÖRPERN UND ANTI-PD-1-ANTIKÖRPERN ZUR BEHANDLUNG VON TUMOREN
SPC Number:

Dates

Filing date:
18/09/2014
Grant date:
20/03/2019
EP Publication Date:
14/06/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/03/2019
EP B1 Publication Date:
20/03/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/09/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/03/2019
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543-4000, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
30/04/2019
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
LONBERG, Nils
Address:
United States (US)

2

Name:
KORMAN, Alan J.
Address:
United States (US)

3

Name:
LEWIS, Katherine E.
Address:
United States (US)

4

Name:
GUTIERREZ, Andres A.
Address:
United States (US)

5

Name:
SELBY, Mark J.
Address:
United States (US)

6

Name:
FONTANA, David J.
Address:
United States (US)

Priority

1

Priority Number:
201361880606 P
Priority Date:
20/09/2013
Priority Country:
United States (US)

2

Priority Number:
201462014471 P
Priority Date:
19/06/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61P 35/00; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
201912
Publication date:
20/03/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/09/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56
03/05/2019 Outgoing Correspondence 1
30/04/2019 Power Of Attorney 1